D-0108-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0108-2025 was initiated by AvKARE on Nov 27, 2024 and is designated Class II. Reason for recall: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. The recall status is ongoing. Affected quantity: 50,304 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 11, 2024
Initiation Date
Nov 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
50,304 bottles

Product description

Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-459-30

Reason for recall

CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.

Distribution pattern

USA Nationwide

Code information

Lot#: 44378, 44597, 45804, Exp 12/31/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0108-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0108-2025. Report a data issue: hello@regdatalab.com.